Torres, Tiago https://orcid.org/0000-0003-0404-0870
Puig, Luis
Article History
Received: 9 July 2025
Accepted: 30 July 2025
First Online: 8 August 2025
Declarations
:
: Tiago Torres has received consultancy and/or speaker’s honoraria from and/or participated in clinical trials sponsored by AbbVie, Amgen, Almirall, Amgen, Apogee Therapeutics, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius-Kabi, Johnson & Johnson Innovative Medicine, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz, STADA and UCB. Luis Puig has received consultancy/speaker’s honoraria from and/or participated in clinical trials sponsored by Abbvie, Almirall, Amgen, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Fresenius-Kabi, Horizon (DSMB), J&J Innovative Medicine, Leo-Pharma, Lilly, Novartis, Pfizer, Samsung Bioepis, STADA, Sun-Pharma, Takeda, and UCB.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.